They observed that patients with high IFI44L levels in MDS had a more unfavorable prognosis (73), additionally, it may affect pancreatic cancer growth through mechanisms of cell-matrix adhesion and extracellular matrix, suggesting that IFI44L could serve as a valuable and significant survival indicator in MDS. The gene discussed is IFI44L; the disease is familial pancreatic carcinoma.